JP2022514786A5 - - Google Patents
Info
- Publication number
- JP2022514786A5 JP2022514786A5 JP2021536253A JP2021536253A JP2022514786A5 JP 2022514786 A5 JP2022514786 A5 JP 2022514786A5 JP 2021536253 A JP2021536253 A JP 2021536253A JP 2021536253 A JP2021536253 A JP 2021536253A JP 2022514786 A5 JP2022514786 A5 JP 2022514786A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024181493A JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/122572 | 2018-12-21 | ||
| CN2018122572 | 2018-12-21 | ||
| PCT/US2019/067457 WO2020132232A2 (en) | 2018-12-21 | 2019-12-19 | Antibodies specific to muc18 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024181493A Division JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022514786A JP2022514786A (ja) | 2022-02-15 |
| JP2022514786A5 true JP2022514786A5 (https=) | 2022-12-16 |
| JPWO2020132232A5 JPWO2020132232A5 (https=) | 2022-12-16 |
| JP7578289B2 JP7578289B2 (ja) | 2024-11-06 |
Family
ID=71101906
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536253A Active JP7578289B2 (ja) | 2018-12-21 | 2019-12-19 | Ｍｕｃ１８に特異的な抗体 |
| JP2024181493A Pending JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024181493A Pending JP2025026839A (ja) | 2018-12-21 | 2024-10-17 | Ｍｕｃ１８に特異的な抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12364770B2 (https=) |
| EP (1) | EP3898964A4 (https=) |
| JP (2) | JP7578289B2 (https=) |
| CN (2) | CN117343187A (https=) |
| AU (2) | AU2019401657B2 (https=) |
| TW (2) | TW202519555A (https=) |
| WO (1) | WO2020132232A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020132190A1 (en) | 2018-12-21 | 2020-06-25 | Multitude Inc. | Antibodies specific to muc18 |
| WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2024081820A1 (en) | 2022-10-13 | 2024-04-18 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| KR20260016952A (ko) | 2023-05-23 | 2026-02-04 | 사나 바이오테크놀로지, 인크. | 탠덤 퓨소젠 및 관련 지질 입자 |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6824995B1 (en) * | 1998-03-03 | 2004-11-30 | Emory University | Diagnostic for metastatic prostate cancer |
| EP1467756A4 (en) * | 2001-12-28 | 2007-03-21 | Abgenix Inc | METHODS OF USING ANTI-MUC18 ANTIBODIES |
| CA2471849A1 (en) * | 2001-12-28 | 2003-07-17 | Abgenix, Inc. | Antibodies against the muc18 antigen |
| KR101672271B1 (ko) * | 2007-12-18 | 2016-11-03 | 바이오얼라이언스 씨.브이. | 암세포에서 발현된 ｃｄ-43 및 ｃｅａ 상의 탄수화물 함유 에피토프를 인식하는 항체 및 그것의 사용 방법 |
| CN102936283B (zh) * | 2008-01-31 | 2014-11-05 | 中国科学院生物物理研究所 | 抗人cd146的单克隆抗体，包含其的组合物，检测可溶性cd146的方法 |
| EP2430051B1 (en) | 2009-05-14 | 2016-03-23 | Institut National de la Santé et de la Recherche Medicale | Compositions containing antibodies for treating cd5+ hla-dr+ b or t cell related diseases |
| TWI660972B (zh) * | 2012-09-10 | 2019-06-01 | 愛爾蘭商尼歐托普生物科學公司 | 抗ｍｃａｍ抗體及相關使用方法 |
| WO2015044218A1 (en) * | 2013-09-24 | 2015-04-02 | Oncoinvent As | Monoclonal antibody and derivatives |
| PT3116911T (pt) | 2014-03-12 | 2019-09-04 | Prothena Biosciences Ltd | Anticorpos anti-mcam e métodos de utilização associados |
| CN104650231A (zh) * | 2015-02-13 | 2015-05-27 | 南京任诺药业有限公司 | 一种具备高效中和活性的人源化抗人cd146单克隆抗体 |
| WO2017046776A2 (en) * | 2015-09-16 | 2017-03-23 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis |
| WO2017149513A1 (en) * | 2016-03-03 | 2017-09-08 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| US20190192573A1 (en) | 2016-08-19 | 2019-06-27 | Oncoinvent As | Anti-osteosarcoma car-t derived from the antibody oi-3 |
| WO2018220467A1 (en) | 2017-05-30 | 2018-12-06 | Foroogh Nejatollahi | Anti-muc18 human immunotoxin and applications thereof |
| CN108129567B (zh) | 2018-01-09 | 2019-02-26 | 南京任诺药业有限公司 | 一种具备高效中和活性的人源化抗人cd146单克隆抗体 |
| WO2020132190A1 (en) | 2018-12-21 | 2020-06-25 | Multitude Inc. | Antibodies specific to muc18 |
-
2019
- 2019-12-19 CN CN202311007127.1A patent/CN117343187A/zh active Pending
- 2019-12-19 JP JP2021536253A patent/JP7578289B2/ja active Active
- 2019-12-19 AU AU2019401657A patent/AU2019401657B2/en active Active
- 2019-12-19 TW TW113130223A patent/TW202519555A/zh unknown
- 2019-12-19 WO PCT/US2019/067457 patent/WO2020132232A2/en not_active Ceased
- 2019-12-19 CN CN201980092138.XA patent/CN113423830B/zh active Active
- 2019-12-19 TW TW108146802A patent/TWI855014B/zh active
- 2019-12-19 EP EP19900282.5A patent/EP3898964A4/en active Pending
-
2021
- 2021-06-17 US US17/351,014 patent/US12364770B2/en active Active
-
2024
- 2024-10-17 JP JP2024181493A patent/JP2025026839A/ja active Pending
-
2025
- 2025-06-16 US US19/239,203 patent/US20250367313A1/en active Pending
- 2025-12-22 AU AU2025283667A patent/AU2025283667A1/en active Pending